Join

Store

Chapters

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now
Menu
Back to Policy Updates

FDA/FTC Issue Warning against Unapproved COVID Products

FDA/FTC Issue Warning against Unapproved COVID Products

The FDA issued a warning letter jointly with the Federal Trade Commission to Alternative Health Distribution LLC d/b/a CannaAid for selling unapproved and misbranded products for use in treating or preventing COVID-19.